JW Therapeutics closes IPO early

By Jonathan Breen
27 Oct 2020

Chinese biotechnology firm JW (Cayman) Therapeutics is set to close the book for its Hong Kong IPO on Tuesday, a daily earlier than planned, according to a source familiar with the matter.

Sponsors Goldman Sachs and UBS kicked off bookbuilding for the company on October 22. By the following morning, the IPO was multiples times covered across the marketed price range, said the source.

JW is floating 97.7m shares at HK$20.00 to HK$23.80 ($2.58 to $3.07), meaning it could raise ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial